Volume : IV, Issue : VII, July - 2015


Dr. Anurag Prasad, Dr. Anubhav Gupta

Abstract :

 Introduction: Diabetic ketoacidosis (DKA) is an acute, major, life–threatening complication of diabetes. Recently, new analogues of human insulin aspart are used in treatment of mild to moderate diabetic ketoacidosis. AIM: To study the role of subcutaneous insulin aspart in management of diabetic ketoacidosis. Results: The mean duration of treatment until glucose concentration was <13.8 mmol/l (<25omg/dl) was not statistically different between patients treated with SC–1h (6.8 + 3h) and SC–2h (6.5+ 3h) or with IV regular insulin (6.9 + 4h). Similarly, the mean duration of treatment until resolution of ketoacidosis was not statistically different among treatment groups 10.3 + 3, 10.8 + 3 and 10.5 + 3 h respectively. Conclusions: Treatment with subcutaneous insulin aspart 1 hourly/2hourly represent a safe and effective alternative to intravenous regular insulin in mild to moderate form of diabetic ketoacidosis.

Article: Download PDF    DOI : https://www.doi.org/10.36106/paripex  

Cite This Article:

Dr. Anurag Prasad, Dr. Anubhav Gupta Role of Insulin Aspart in Management of Diabetic Ketoacidosis. Paripex-Indian Journal Of Research, Vol: 4, Issue : 7 July 2015

Number of Downloads : 338

References :